Previous studies on the biomarkers of glioma mainly focused on epidermal growth factor receptor (EFGR) amplification, chromosome 1p/19q deletion, O6-methylguanine DNA methyltransferase (MGMT) promoter methylation, and isocitrate dehydrogenase (IDH) mutations (5, 6). Here, MGMT is linked to central nervous system cancer.